FDA Drug Application (022405) for CAPRELSA by GENZYME CORP

Back to FDA Applications sponsored by GENZYME CORP

Application Number022405
Product Number001
FormTABLET;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCAPRELSA
Active IngredientVANDETANIB



Back to FDA Applications sponsored by GENZYME CORP